chr5-240396-G-T
Variant summary
Our verdict is Likely pathogenic. Variant got 9 ACMG points: 9P and 0B. PVS1PP5
The NM_004168.4(SDHA):c.1471G>T(p.Glu491Ter) variant causes a stop gained change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000621 in 1,609,890 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_004168.4 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 9 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SDHA | NM_004168.4 | c.1471G>T | p.Glu491Ter | stop_gained | 11/15 | ENST00000264932.11 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SDHA | ENST00000264932.11 | c.1471G>T | p.Glu491Ter | stop_gained | 11/15 | 1 | NM_004168.4 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152200Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000400 AC: 1AN: 249978Hom.: 0 AF XY: 0.00000738 AC XY: 1AN XY: 135524
GnomAD4 exome AF: 0.00000617 AC: 9AN: 1457690Hom.: 0 Cov.: 29 AF XY: 0.00000827 AC XY: 6AN XY: 725366
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152200Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74360
ClinVar
Submissions by phenotype
not provided Pathogenic:2
Likely pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Apr 07, 2023 | Nonsense variant predicted to result in nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); Has not been previously published as pathogenic or benign to our knowledge; This variant is associated with the following publications: (PMID: 23109135) - |
Pathogenic, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Mar 01, 2018 | - - |
SDHA-related disorder Pathogenic:1Uncertain:1
Pathogenic, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | May 06, 2024 | The SDHA c.1471G>T variant is predicted to result in premature protein termination (p.Glu491*). This variant has been reported in an individual with osteosarcoma (Table S5 in Mirabello et al. 2020. PubMed ID: 32191290). This variant is reported in 0.00088% of alleles in individuals of European (Non-Finnish) descent in gnomAD. Nonsense variants in SDHA are expected to be pathogenic. This variant has conflicting interpretations in ClinVar, with the majority being pathogenic or likely pathogenic (https://www.ncbi.nlm.nih.gov/clinvar/variation/472289/). We interpret c.1471G>T (p.Glu491*) as pathogenic. - |
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | May 03, 2018 | The SDHA c.1471G>T (p.Glu491Ter) variant is a stop-gained variant. The p.Glu491Ter variant has been reported in a homozygous state in one gastrointestinal stromal tumor (GIST) sample from a single patient (Belinsky et al. 2013). SNP analysis suggested a loss of the wild type allele in the tumor through a copy number loss, but the genomic DNA was unavailable for analysis. Another individual affected with GIST was found to carry a stop-gained variant, p.Glu490Ter, at the adjacent amino acid position in an unknown zygosity (Casey et al. 2017). The p.Glu491Ter variant is reported at a frequency of 0.00002 in the European (non-Finnish) population of the Exome Aggregation Consortium but this is based on one allele in a region of good sequencing coverage so the variant is presumed to be rare. The p.Glu491Ter variant has not been identified in patients with Leigh syndrome or mitochondrial respiratory chain complex II deficiency. Due to the potential impact of stop-gained variants and the limited clinical evidence, p.Glu491Ter variant is classified as a variant of unknown significance but suspicious for pathogenicity for SDHA-related disorders. This variant was observed by ICSL as part of a predisposition screen in an ostensibly healthy population. - |
Paragangliomas 5;C5700310:Mitochondrial complex II deficiency, nuclear type 1 Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 30, 2024 | This sequence change creates a premature translational stop signal (p.Glu491*) in the SDHA gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in SDHA are known to be pathogenic (PMID: 22974104, 24781757). This variant is present in population databases (rs778207102, gnomAD 0.0009%). This variant has not been reported in the literature in individuals affected with SDHA-related conditions. ClinVar contains an entry for this variant (Variation ID: 472289). For these reasons, this variant has been classified as Pathogenic. - |
Dilated cardiomyopathy 1GG Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | Aug 18, 2023 | - - |
Hereditary cancer-predisposing syndrome Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 07, 2021 | The p.E491* pathogenic mutation (also known as c.1471G>T), located in coding exon 11 of the SDHA gene, results from a G to T substitution at nucleotide position 1471. This changes the amino acid from a glutamic acid to a stop codon within coding exon 11. This variant is considered to be rare based on population cohorts in the Genome Aggregation Database (gnomAD). This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. - |
Neurodegeneration with ataxia and late-onset optic atrophy Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Apr 30, 2024 | Variant summary: SDHA c.1471G>T (p.Glu491X) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. The variant allele was found at a frequency of 4e-06 in 249978 control chromosomes. c.1471G>T has been reported in the literature in at least one individual affected with paraganglioma (example: Ding_2022). The following publication has been ascertained in the context of this evaluation (PMID: 35546442). ClinVar contains an entry for this variant (Variation ID: 472289). Based on the evidence outlined above, the variant was classified as pathogenic. - |
Paragangliomas 5 Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Myriad Genetics, Inc. | Feb 08, 2024 | This variant is considered pathogenic. This variant creates a termination codon and is predicted to result in premature protein truncation. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at